ARase Therapeutics
1 known investors
Arase Therapeutics develops first-in-class oncology therapeutics that target ADP-ribose Hydrolases, novel proteins in cancer stress pathways. The company focuses on developing new cancer treatments for patients with various cancer types.
BiotechMedical Devices
Founders & leadership
PC
Paul ChangPresident, CEO / CSO and Lead Founder
WL
W. Lee KrausScientific Founder
MT
Michael TaylorExecutive Chairman
Investors · 1
In the news
- Careers - ARase Therapeuticsarasetherapeutics.com · 2023
- HitGen Announces Drug Discovery Research Agreement with ARase Therapeuticsmedtechalert.com · 2023
- ARase Therapeutics - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2022
- Two VCs Raise Over $1 Billion for New Health Care Innovation - BioSpacebiospace.com · 2021
- VC shop Mission BioCapital raises $275M 5th fund with focus on incubating startups | Fierce Biotechfiercebiotech.com · 2021